For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $1.89 in the prior trading day, Palisade Bio Inc (NASDAQ: PALI) closed at $1.75, down -7.41%. In other words, the price has decreased by -$7.41 from its previous closing price. On the day, 5.91 million shares were traded. PALI stock price reached its highest trading level at $1.89 during the session, while it also had its lowest trading level at $1.71.
Ratios:
Our goal is to gain a better understanding of PALI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.78. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, B. Riley Securities on January 09, 2026, initiated with a Buy rating and assigned the stock a target price of $7.
On December 29, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 16 ’26 when Williams Donald Allen bought 5,000 shares for $1.67 per share. The transaction valued at 8,356 led to the insider holds 10,728 shares of the business.
Williams Donald Allen bought 5,000 shares of PALI for $9,400 on Jan 09 ’26. The Director now owns 5,728 shares after completing the transaction at $1.88 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PALI now has a Market Capitalization of 261105632 and an Enterprise Value of 255741616.
Stock Price History:
The Beta on a monthly basis for PALI is 1.62, which has changed by 0.277027 over the last 52 weeks, in comparison to a change of 0.110832214 over the same period for the S&P500. Over the past 52 weeks, PALI has reached a high of $2.64, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is -12.02%, while the 200-Day Moving Average is calculated to be 45.45%.
Shares Statistics:
The stock has traded on average 5.26M shares per day over the past 3-months and 6993310 shares per day over the last 10 days, according to various share statistics. A total of 149.00M shares are outstanding, with a floating share count of 139.73M. Insiders hold about 6.22% of the company’s shares, while institutions hold 38.45% stake in the company. Shares short for PALI as of 1767139200 were 15949282 with a Short Ratio of 3.03, compared to 1764288000 on 13976371. Therefore, it implies a Short% of Shares Outstanding of 15949282 and a Short% of Float of 10.71.
Earnings Estimates
. The current market rating for Palisade Bio Inc (PALI) reflects the collective analysis of 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.03 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.18 and -$1.48 for the fiscal current year, implying an average EPS of -$0.53. EPS for the following year is -$0.23, with 5.0 analysts recommending between -$0.09 and -$0.33.
